Hyloris announces enrolment of first patient in a 4-arm clinical trial of Alenura(TM)

Potential first-line treatment for interstitial cystitis/bladder pain syndrome (IC/BPS)Global opportunity with a patient population of at least 6 million in the U.S. alone1 Liège, Belgium – 22 June 2023 – 7AM CET –